Celecoxib
Product Images NDC 70882-129

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Celecoxib (NDC 70882-129). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cambridge Therapeutics Technologies, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Celecoxib Capsules Aurobindo 1)

Chemical structure diagram of the active ingredient celecoxib. The diagram shows the molecular arrangement including sulfonamide, trifluoromethyl, and methyl functional groups attached to aromatic rings.*

FDA Label Image

Celecoxib Capsules 200 mg (Celecoxib Capsules Aurobindo 2)

Packaging label for Celecoxib Capsules, 200 mg, manufactured for Cambridge Therapeutic Technologies, LLC. The label shows the capsules image and highlights dosage strength 200 mg. It includes warnings, pharmacist instructions, lot and expiry information spaces, barcodes, and packaging details by Legacy Pharmaceutical Packaging, LLC. The label features company logos and production site information from Aurobindo Pharma Limited.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.